552 related articles for article (PubMed ID: 4993105)
1. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
2. [New viewpoints for indication for radiologic treatment in leukoses and retikuloses].
Musshoff K
Strahlentherapie; 1968 Jun; 135(6):641-55. PubMed ID: 4878792
[No Abstract] [Full Text] [Related]
3. [Results of cytostatic therapy of malignant hemoblastoses].
Stacher A
Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
[No Abstract] [Full Text] [Related]
4. [Rehabilitation and cure of patients with hemoblastoses].
Gerhartz H
Dtsch Med J; 1968 Mar; 19(5):161-3. PubMed ID: 4887782
[No Abstract] [Full Text] [Related]
5. [Drug therapy in hemoblastosis].
Bischof B
Folia Clin Int (Barc); 1968 Jun; 18(6):365-8. PubMed ID: 4988909
[No Abstract] [Full Text] [Related]
6. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies].
Marcolongo R; Bianco G; Di Paolo N; Bravi A
Minerva Med; 1970 Oct; 61(82):4532-41. PubMed ID: 5273365
[No Abstract] [Full Text] [Related]
7. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
8. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
Danieli G
G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
[No Abstract] [Full Text] [Related]
9. [Therapeutic progress and iatrogenic problems in malignant hemopathies].
Geib KR; Papazian R
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):343-9. PubMed ID: 22916
[No Abstract] [Full Text] [Related]
10. Trenimon treatment in chronic hemoblastoses.
Quattrin N; Dini E; Montuori R
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):145-52. PubMed ID: 4968994
[No Abstract] [Full Text] [Related]
11. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases].
Cajozzo A; Citarrella P; Carreca I; D'Eredità F
Haematologica; 1970; 55(7):465-70. PubMed ID: 4996520
[No Abstract] [Full Text] [Related]
12. Leukemia and lymphoma.
White LP
Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
[No Abstract] [Full Text] [Related]
13. [Experiences with intense cytostatic therapy of malignant tumors].
Siering H; Reinhardt M
Arzneimittelforschung; 1968 Sep; 18(9):1182-91. PubMed ID: 4885374
[No Abstract] [Full Text] [Related]
14. [Life expectancy of hemoblastosis patients].
Obrecht P
Med Klin; 1966 Dec; 61(50):1985-90. PubMed ID: 5239386
[No Abstract] [Full Text] [Related]
15. [The treatment of chronic hemoblastosis with new cytostatic agents].
Quattrin N
Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017
[No Abstract] [Full Text] [Related]
16. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
17. [Quantitative immunoglobulin determination as a monitoring technic in hematologic diseases under cytostatic therapy].
Knolle J; Wörz R; Meyer zum Büschenfelde
Verh Dtsch Ges Inn Med; 1969; 75():492-7. PubMed ID: 4099583
[No Abstract] [Full Text] [Related]
18. [Mithramycin therapy of hypercalcemia in patients with neoplastic diseases].
Skovgaard M
Ugeskr Laeger; 1974 Aug; 136(32):1814-7. PubMed ID: 4277881
[No Abstract] [Full Text] [Related]
19. [Results in the chemotherapy of malignant lymphomas].
Jahn H; Syrbe G; Kühn RA; Ruffert K; Jorke D; Katenkamp D; Kob D; Löbe LP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):691-3. PubMed ID: 6172335
[No Abstract] [Full Text] [Related]
20. Adrenal steroids in the treatment of malignant hematologic disease.
Cline MJ
Med Clin North Am; 1973 Sep; 57(5):1203-9. PubMed ID: 4205834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
